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Abstract
Background: Evaluation of lymph node involvement is an important factor in detecting metastasis and deciding
whether to perform axillary lymph node dissection (ALND) in breast cancer surgery. As ALND is associated with
potentially severe long term morbidity, the accuracy of lymph node assessment is imperative in avoiding
unnecessary ALND. The mechanical properties of malignant lymph nodes are often distinct from those of normal
nodes. A method to image the micro-scale mechanical properties of lymph nodes could, thus, provide diagnostic
information to aid in the assessment of lymph node involvement in metastatic cancer. In this study, we scan axillary
lymph nodes, freshly excised from breast cancer patients, with optical coherence micro-elastography (OCME), a
method of imaging micro-scale mechanical strain, to assess its potential for the intraoperative assessment of lymph
node involvement.
Methods: Twenty-six fresh, unstained lymph nodes were imaged from 15 patients undergoing mastectomy or
breast-conserving surgery with axillary clearance. Lymph node specimens were bisected to allow imaging of the
internal face of each node. Co-located OCME and optical coherence tomography (OCT) scans were taken of each
sample, and the results compared to standard post-operative hematoxylin-and-eosin-stained histology.
Results: The optical backscattering signal provided by OCT alone may not provide reliable differentiation by
inspection between benign and malignant lymphoid tissue. Alternatively, OCME highlights local changes in
tissue strain that correspond to malignancy and are distinct from strain patterns in benign lymphoid tissue. The
mechanical contrast provided by OCME complements the optical contrast provided by OCT and aids in the
differentiation of malignant tumor from uninvolved lymphoid tissue.
Conclusion: The combination of OCME and OCT images represents a promising method for the identification of
malignant lymphoid tissue. This method shows potential to provide intraoperative assessment of lymph node
involvement, thus, preventing unnecessary removal of uninvolved tissues and improving patient outcomes.
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Background
The presence of lymph node metastasis is one of the
primary prognostic indicators for patients with early-
stage breast cancer [1–3]. During surgery, the sentinel
lymph node (SLN) (the first-draining node) is often ex-
cised and assessed. If the SLN is found to be involved,
axillary lymph node dissection (ALND) is often per-
formed to determine if the disease is present in the
lymphatic system and to prevent its further spread [3].
However, ALND is associated with potentially signifi-
cant long term morbidity, such as seroma formation, al-
tered sensation in the upper limb, and lymphedema [4].
The accuracy of SLN assessment is, thus, imperative in
avoiding unnecessary ALND. Current pre- and intra-
operative SLN assessment techniques include macro-
scopic examination, pathology, and medical imaging
[5]. Macroscopic assessment is subjective; for example,
when performing visual inspection and palpation alone,
inflammation in nodes may be mistaken for malignancy
[6]. Intraoperative pathology techniques, including frozen
section and imprint cytology, provide high-resolution,
highly specific assessment of lymph node morphology, but
are often expensive, time-consuming (20–40 min), and
can sample only a small proportion of the lymph node
within an intraoperative timeframe [7]. This can result in
low diagnostic accuracy: the sensitivities of frozen sec-
tion and imprint cytology have been reported to be in
the range 53–74 %, with corresponding specificities of
98–100 % [8, 9]. Medical imaging, including magnetic
resonance imaging (MRI) [10], ultrasound (US) [11],
and positron emission tomography/X-ray computed
tomography (PET-CT) [12], have also been proposed
for preoperative staging of the axilla. These techniques
rely predominantly on assessment of the size and shape
of the nodes, as they do not typically have the resolution
required to visualize micro-scale lymph node morphology,
limiting their potential for SLN assessment. For example,
these medical imaging techniques can have difficulty in
distinguishing metastatic and reactive nodes [11].
New techniques for rapid, accurate, intraoperative
assessment of the SLN have the potential to improve
surgical decision-making, ultimately leading to improved
patient outcomes. Methods such as high-frequency ultra-
sound (HF-US) [13] and photoacoustic tomography (PAT)
[14] have been investigated, reporting spatial resolutions
of ~100 μm (HF-US) or ~50 μm (PAT); additionally, PAT
has been used in conjunction with external contrast
agents. To obtain improved spatial resolution without the
need for labelling agents, optical modalities, such as op-
tical coherence tomography (OCT), often described as the
optical analog to ultrasonography, have been proposed
[15–22]. The detection of backscattered light, rather than
sound, provides OCT with a spatial resolution of 1–
20 μm, but only to a depth of 1–2 mm in turbid tissue.
OCT has the potential to rapidly scan entire ex vivo lymph
nodes intraoperatively, improving upon the sampling is-
sues of intraoperative histopathology techniques. However,
it is unclear if lymph node metastases can be adequately
delineated based on endogenous optical scattering con-
trast alone [21, 22].
It has previously been established that the mechanical
properties of malignant lymph nodes are often distinct
to those of normal nodes [23, 24]. Mapping the micro-
scale mechanical properties of lymph nodes could, thus,
provide additional diagnostic information to comple-
ment that provided by OCT. Over the past 25 years,
various imaging techniques, collectively termed elasto-
graphy, have emerged to map the mechanical properties
of tissues. Elastography uses an imaging modality, most
commonly US [25] or MRI [26], to measure tissue de-
formation in response to a mechanical load. Tissue
mechanical properties are then estimated using a mech-
anical model, and mapped onto an image, known as an
elastogram. Several studies have investigated the use of
US elastography to assess axillary lymph nodes [27, 28].
However, the spatial resolution of elastography is ultim-
ately limited by the underlying imaging modality, which,
using US or MRI, may be insufficient to detect lymph
node metastasis.
Optical coherence elastography (OCE) [29–32] uses
OCT as the underlying modality and, thus, has a higher
spatial resolution than US- or MRI-based elastography [30].
Our group has recently demonstrated a variant of OCE,
dubbed optical coherence micro-elastography (OCME),
which has a lateral resolution matched to that of OCT over
en face fields of view up to ~20 × 20 mm [33]. In OCME, a
uniform compressive load is applied to the specimen, and
3-D elastograms are generated of the resulting mechanical
strain, which is inversely proportional to the tissue stiffness.
We have shown that this technique can provide contrast
between malignant and normal tissue in fresh, excised hu-
man breast specimens [33, 34].
Here, we utilized OCME to scan axillary lymph nodes,
freshly excised from human breast cancer patients, to in-
vestigate its potential for the intraoperative assessment of
lymph nodes. We imaged 26 specimens from 15 patients
undergoing a mastectomy or breast-conserving surgery
with axillary clearance and present co-located histology,
OCT images, and elastograms of selected representative
cases. The results show that OCME provides contrast that
is additional and complementary to that provided by OCT
and demonstrate the potential of OCME for intraoperative
SLN assessment.
Methods
Imaging system
A portable OCE system, described in detail previously
[33, 34], was used in this study. The system utilizes an
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835-nm, spectrometer-based OCT system, with axial/
lateral resolutions of 8 μm/11 μm (in air), respectively.
3-D datasets were acquired in ~17 min, with dimen-
sions (x × y × z) up to 10 × 10 × 1.5 mm, comprising
1000 line scans (A-scans) in each 2-D image (B-scan)
and 10,000 B-scans in each volume (C-scan). An annu-
lar piezoelectric transducer (Piezomechanik, Germany)
with a glass window fixed to the surface was used to
enable imaging and mechanical loading from the same
side of the sample [33, 34]. Figure 1 shows a schematic
diagram of this imaging system.
Imaging protocol
To ensure even contact with the window, the specimen
was preloaded prior to imaging by applying ~10–20 %
compression. During imaging, the transducer displaced
the tissue surface by up to a maximum of ~2 μm, at a
frequency of 5 Hz, and was synchronized with the OCT
acquisition such that consecutive B-scans were acquired
in the unloaded then loaded state. The local axial tissue
displacement was proportional to the phase difference
between corresponding A-scans in consecutive B-scans,
as measured using phase-sensitive OCT [35]. Five pairs
of B-scans were recorded and averaged at each y-pos-
ition to improve the precision of the measured displace-
ment [33]. A phase-unwrapping algorithm, described
previously, was used to improve the dynamic range of
measurable displacements [33]. Elastograms were gener-
ated from the displacement maps by calculating the local
strain (change in displacement assessed over an axial
depth range of 100 μm, which defined the elastogram
axial resolution) throughout the sample using a weighted
least-squares linear regression algorithm [33]. The lateral
(x,y) resolution of the elastograms matched that of the
OCT system (11 μm). All datasets were processed using
custom software implemented in Matlab (Mathworks,
USA, v2012b).
OCT is effective in identifying adipose, which exhibits
optical scattering patterns distinct from those of other
tissues. However, the low OCT signal within adipose
cells introduces significant noise into the elastograms.
Adipose, and other areas of low OCT signal, were
manually segmented from the elastograms using image
processing software (GNU Image Manipulation Pro-
gram, v2.8.14), and the remaining OCME data (elasto-
gram) overlaid onto the OCT image [34]. Elastograms
are presented on a linear false-color scale in millistrain
(mε), i.e., length change per unit length × 10−3, and
OCT images are presented on a logarithmic decibel
(dB) grayscale. As the amount of contrast provided by
OCME is dependent on the sample structure and ap-
plied load [34] (see Discussion), the color-scale of the
presented elastograms was chosen to maximize the
available image contrast. The presented en face OCT
images and elastograms are taken from within 300 μm
of the sample surface, chosen as the en face images that
best matched the corresponding histology.
Tissue preparation
Informed consent was obtained from patients and the
study approved by the Human Ethics Committee of Sir
Charles Gairdner Hospital, Perth, Western Australia.
Twenty-six specimens were imaged from 15 patients
undergoing a mastectomy or breast-conserving surgery
with axillary clearance. Samples were bisected to allow
imaging of the internal face of each node and kept hy-
drated in saline until imaging, which occurred within 1–
2 h of excision. After imaging, specimens were fixed in
10 % neutral buffered formalin, embedded in paraffin,
sectioned and stained with hematoxylin and eosin
(H&E), following standard histopathology protocols. The
H&E-stained sections were digitally micrographed
(ScanScope, Leica Biosystems, Nussloch, Germany) and
manually co-registered with the corresponding en face
elastograms and en face OCT images. Interpretation of
histology was performed by an experienced pathologist
(B. Latham).
Results
Figure 2 shows an example of a normal, benign lymph
node. The histology (Fig. 2a) shows that the node has a
fibrous capsule (C) separating the lymphoid tissue from
surrounding adipose (A). Several follicles (F) comprising
Fig. 1 a Schematic of the imaging system used in this study. Collimator
(C), 50/50 fiber coupler (FC), objective lens (OL), polarization controller
(PC), scanning galvanometer (SG), superluminescent diode light source
(SLD), spectrometer (SM). b Schematic (side view) of the sample stage,
corresponding to the region within the red box in (a). Glass window
(GW), piezoelectric ring actuator (RA), reference reflector (RR)
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sheets of lymphocytes are observed in the cortex of the
node. Below the cortex, the medulla comprises medullary
cords separated by medullary sinuses (MS). Fibrous tra-
beculae (Tr) are also visible. In the OCT image (Fig. 2b),
the fibrous capsule is distinguished by higher backscatter-
ing, and the surrounding adipose provides a distinctive
honeycomb structure. Thin strands of high backscattering,
corresponding to collagen fibers in the trabeculae and me-
dullary sinuses, are present throughout the node. In the
elastogram (Fig. 2c), the capsule is identified by an abrupt
change in strain. The elastogram provides additional con-
trast of trabeculae compared to the OCT. The follicles
present as oval-shaped regions that are separated by
changes in strain caused by surrounding trabeculae and si-
nuses. Smaller, irregularly shaped local areas of greater
negative (compressive) strain in the medulla correspond
to medullary sinuses.
Figure 3 shows a lymph node containing a ~3 mm-
diameter region of metastatic tumor (T). The remain-
der of the sample is normal lymphoid tissue and con-
tains several follicles (F) with relatively large germinal
centers. Fibrous trabeculae (Tr) are also observed run-
ning through the normal portion of the node. The OCT
image (Fig. 3b) highlights areas of collagen, including
the trabeculae, and some follicles are also distinguish-
able. The OCT image does not, however, provide con-
trast between the normal and malignant regions. On
the other hand, the tumor is readily differentiated from
normal tissue in the elastogram (Fig. 3c). Strain hetero-
geneity within the malignant region is attributed to
groups of tumor cells separated by fibrous bands.
Within the normal region of the lymph node, pockets
of high negative strain correspond to germinal centers
within follicles.
Figure 4 shows a lymph node containing a ~3 × 1 mm
region of metastatic tumor (T) classified as pleomorphic
lobular carcinoma. The top left of the node contains
mainly sheets of tumor cells, and these become gradually
more interspersed with lymphocytes and macrophages
toward the right of the sample. The far right of the sam-
ple is normal lymphoid tissue and contains follicles (F).
The central region consists of a band of stroma, contain-
ing several vessels (V), surrounded by adipose (A). The
OCT image (Fig. 4b) again exhibits higher backscatter-
ing in the areas of dense stroma, including the capsule
(C), but presents an otherwise homogeneous signal. The
elastogram (Fig. 4c) reveals a region of high negative
strain at the far left corresponding to a region of solid
tumor cells delineated by stroma. The elastogram is also
highly heterogeneous in the central region of stroma,
particularly around vessels. The remainder of the region
of solid tumor cells presents as mostly homogeneous
strain. The far right of the sample, corresponding to nor-
mal lymph node, contains small, local areas of negative
strain, more similar to the heterogeneity seen in areas of
normal lymph node in Figs. 2 and 3.
Figure 5 shows a region of a lymph node in which nor-
mal tissue has been largely replaced by malignancy. The
histology reveals an area of fibrotic stroma (S) toward
the center of the sample, with an area of necrosis (N)
present, surrounded by tumor interspersed with stroma
(T). In the OCT image (Fig. 5b), the capsule (C), as well
as the region of fibrosis, can be identified as regions of
higher backscattering. The elastogram (Fig. 5c) provides
much higher contrast between the capsule and the stroma
than OCT. The region of fibrosis presents as homoge-
neous strain, indicating its mechanical uniformity. In areas
where tumor cells are interspersed with desmoplastic
stroma, heterogeneous strain is present.
Discussion
In this study, we have presented representative elastograms,
with corresponding OCT and histology, selected from 26
fresh, unstained specimens. In benign and involved lymph
Fig. 2 Benign lymph node sample. a H&E-stained histology, (b) en face OCT image, and (c) elastogram overlaid on OCT. Adipose (A), capsule (C),
follicle (F), medullary sinuses (MS), trabeculae (Tr)
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Fig. 3 Lymph node containing metastasis. a H&E-stained histology, (b) en face OCT image, and (c) elastogram overlaid on OCT. Follicle (F), tumor
(T), trabeculae (Tr)
Fig. 4 Lymph node containing pleomorphic lobular carcinoma. a H&E-stained histology, (b) en face OCT image, and (c) elastogram overlaid on
OCT. Adipose (A), capsule (C), follicle (F), tumor (T), vessel (V)
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nodes, we observed features such as adipose, capsule, folli-
cles, and trabeculae. As with our previous OCME studies
on human breast tissue [33, 34], the results show that
OCME provides additional contrast that is complementary
to that provided by OCT alone. This complementary infor-
mation is presented using image fusion to combine the en
face elastograms with the OCT images, in a similar manner
to that employed by existing medical imaging techniques,
such as MRI and PET-CT [36]. The contrast observed in
the elastograms consists of both negative (compressive)
strain, as expected, and also positive (tensile or compressive
in the direction opposed to the applied force) strain. This
accentuates feature contrast, and is a reflection of the struc-
tural heterogeneity of the tissue [34].
In the OCT images (Part b, Figs. 2, 3, 4 and 5), adipose
is readily distinguished by its distinct ‘honeycomb’ appear-
ance. The capsule surrounding the lymph node can be
seen as a band of higher backscatter in OCT, and as
abrupt changes in strain in OCME. Follicles make up
much of the structure of healthy lymph nodes (Fig. 2),
with the trabeculae between the follicles visible as bands
of higher backscattering (OCT, Fig. 2b), and discontinu-
ities in the strain pattern (OCME, Fig. 2c). Regions of
tumor typically appear in the OCT images as areas of
homogeneous signal, with few distinguishing features
(Part b, Figs. 3, 4 and 5). The same regions can often be
distinguished in the elastograms (Part c, Figs. 3, 4 and 5),
exhibiting strain patterns distinct from that of uninvolved
follicles (Fig. 2c). Consistent with our previous studies in
breast tissue, regions of solid tumor cells result in homo-
geneous strain patterns; whereas, regions containing
tumor mixed with desmoplastic stroma result in heteroge-
neous strain [34]. On the cellular level, tumor cells are
often softer than the collagen-rich stroma [37, 38], which
is likely the cause of the heterogeneous strain patterns ob-
served in these mixed regions. Although the appearance
of tumor varies notably from specimen to specimen, in all
the cases we examined the strain patterns can be linked to
the underlying micro-scale tissue constituents and archi-
tecture and, in most cases, the mechanical contrast in re-
gions of malignancy improves upon that provided by
OCT alone. This is most noticeable in Fig. 5, where the
fine structure seen in the OCME of the tumor on the right
of the image is absent from the OCT images. Further
study is required to ascertain the extent to which these
visual features are consistent over the larger population.
However, we have found that the mechanical contrast pro-
vided by OCME complements the optical contrast pro-
vided by OCT, and aids in the distinction of malignant
from benign lymph node tissue.
Previous studies in assessing lymph node involvement
using OCT imaging alone have reported sensitivity/
specificities of 92 %/83 % by Grieve et al. [21], and
59 %/81 % by Nolan et al. [22]. Grieve et al.’s results
demonstrate the benefits of using high resolution OCT
(~1 μm, approaching the ~0.5 μm of typically hist-
ology). However, this high resolution is achieved at the
expense of a low depth of field (DOF, ~10 μm, using a
white light source and a water immersion lens with a
numerical aperture of 0.3) [21], compared to the DOF
of ~0.5 mm of standard OCT (near-infrared light, lens
numerical aperture of ~0.03–0.04). Low DOF typically
implies that either the sample or the imaging lens must
be physically moved in order to acquire in-focus images
from multiple depths, slowing acquisition of 3-D vol-
umes. Nolan et al. used an OCT system with compar-
able resolution to that used in this study (~10 μm) [22],
and their results support our findings that OCT alone
may not be sufficient in reliably detecting lymph node
metastases. Nolan et al. additionally examined multiple
slices through the volume in order to arrive at a diag-
nosis; whereas, our study analyzed a single OCT/
OCME en face image for each sample, chosen from the
depth that best matched the histology section. Full 3-D
examination may potentially allow for improved diag-
nosis within a short time frame, and further study is
Fig. 5 Lymph node largely replaced by metastasis. a H&E-stained histology, (b) en face OCT image, and (c) elastogram overlaid on OCT.
Adipose (A), capsule (C), necrosis (N), stroma (S), tumor (T)
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required to assess the information available from the
full 3-D OCME dataset.
The images presented in this study were obtained from
within 300 μm of the bisected surface of the lymph
nodes. The depth penetration of our OCT system in hu-
man lymphoid tissue was observed to be approximately
500–700 μm; however, the image quality of both OCT
and OCME notably degrades due to attenuation of the
light beam by scattering as we approach this maximum
depth. Bisecting the nodes, as in this study, allows scan-
ning of two internal faces and effectively doubles the
depth information obtained. In future intraoperative
deployment, both the internal and external faces of
bisected nodes could be scanned, which we estimate
would allow sampling of >50 % of the volume of most
lymph nodes, much greater than that achievable using
intraoperative histopathology [39]. The percentage of
the lymph node that should be sampled for OCME to
accurately judge involvement status will form part of a
future study aimed at assessing the sensitivity and spe-
cificity of the technique.
Measurement of local strain in OCME is coupled to
the underlying sample structure and elasticity, and to
the applied load [30, 33, 34]. Related OCE techniques
have been demonstrated that directly estimate elasticity
based on measurement of the propagation velocity of
elastic waves [30–32, 40–42]. However, these techniques
have yet to overcome the challenges necessary to achieve
spatial resolutions comparable with compression OCE
techniques, such as OCME [30–32]. We have recently
shown an adaptation of OCME that determines elasticity
at the surface of tissue, using a compliant silicone layer
with known mechanical properties to account for ap-
plied load [43]. However, the ability to characterize the
elasticity distribution at depth in heterogeneous tissues
is still to be fully investigated. Another possible solution is
to solve for the elasticity distribution using an iterative
computational method [44]. In addition, semi-quantitative
assessment may be possible using a visual grading scale,
relating features seen in OCT and OCME with the pres-
ence and type/grade of tumor.
The results of this study demonstrate that OCME can
visualize multiple salient features of the micro-
architecture of malignant and benign nodes, providing
justification for a larger study, incorporating more speci-
mens and patients, in order to determine the diagnostic
accuracy of the technique (sensitivity and specificity).
Additional study is also required to determine the mini-
mum metastasis size that can be reliably identified with
OCME. We hypothesize that this size will be dependent
on the differences between the mechanical properties of
the particular tumor type and normal lymphoid tissue.
This lower bound is likely to be larger than the smallest
metastasis detectable using histology, as the lateral
resolution of OCME (~10 μm) is much coarser than that
of the optical microscopes used for histology (<0.5 μm).
However, we have recently demonstrated a variant of
OCME with a lateral resolution of 2 μm [45] that may be
able to detect micrometastases of a similar size to those
detectable with histology, and further improvements may
be possible by using an OCT system with even higher
resolution (<1 μm) [21]. Future studies will also aim to
further develop OCME toward providing results within
intraoperative timeframes, which will require significant
increases to acquisition and processing speeds. The
current study acquired 3-D volumes in ~17 min; however,
we have previously demonstrated a method of acquiring
OCME volumes in ~5 s [46], which could be applied to
scanning lymph nodes. Similarly, using the current soft-
ware, each dataset required approximately 1 h to process
on a standard PC. We have recently shown the use of cus-
tom software running on a graphics processing unit to de-
crease this time to under 50 s for datasets of the size
recorded in this study [47]; however, further research is re-
quired to ensure the image quality matches that of the re-
sults shown here.
Conclusion
OCME represents a new method for the identification
of malignant tissue in lymph nodes, with the potential
to be used intraoperatively. In this initial study, we have
demonstrated the correspondence between elastograms
and co-registered histology, as well as the complementary
information provided by OCT and OCME. These results
show the potential for future development of OCME as an
intraoperative tool for assessment of lymph node
involvement.
Abbreviations
ALND: Axillary lymph node dissection; H&E: Hematoxylin and eosin;
MRI: Magnetic resonance imaging; OCE: Optical coherence elastography;
OCME: Optical coherence micro-elastography; OCT: Optical coherence
tomography; PAT: Photoacoustic tomography; PET-CT: Positron emission
tomography/X-ray computed tomography; SLN: Sentinel lymph node;
US: Ultrasound
Acknowledgements
The authors acknowledge the facilities, and the scientific and technical
assistance of the Australian Microscopy and Microanalysis Research Facility
at the Centre for Microscopy, Characterization and Analysis, The University
of Western Australia, a facility funded by the University, State and
Commonwealth Governments. We acknowledge the support of Maxine
Ronald, Jocelyn Lippey, Derek Teh and Wes Allen in acquiring, processing
and interpreting the data.
Funding
This project is supported with funding from the Australian Research Council;
and Cancer Council WA, which allowed us to develop the technology;
Department of Health of Western Australia, National Breast Cancer Foundation
(Australia); and the National Health and Medical Research Council, Australia,
which allowed us to design and implement the clinical protocol, and to
perform the clinical measurements.
Kennedy et al. BMC Cancer  (2016) 16:874 Page 7 of 9
Availability of data and materials
The datasets analyzed during this study are available from the authors on
reasonable request.
Authors’ contributions
KMK and BFK designed and performed the experiments and analyzed the
data. LC developed the signal processing chain. PW and RAM assisted with
the imaging experiments. BL performed tissue dissection and interpreted
histology. RAM, CMS and BFK coordinated clinical imaging. CMS performed
surgeries and facilitated access to tissue. DDS and BFK conceived, directed
and guided the work. KMK, LC and BFK wrote the manuscript, which was
reviewed and revised by all authors. All authors read and approved the final
manuscript.
Competing interests
The authors are currently in negotiations to explore commercialization of
optical coherence micro-elastography.
Consent for publication
Written informed consent for publication of their clinical data was obtained
from all patients. A copy of the consent form is available for review by the
Editor of this journal.
Ethics approval and consent to participate
Informed consent was obtained from patients and the study approved by
the Human Ethics Committee of Sir Charles Gairdner Hospital, Perth, Western
Australia.
Author details
1Optical+Biomedical Engineering Laboratory, School of Electrical, Electronic &
Computer Engineering, The University of Western Australia, 35 Stirling
Highway, Perth, WA 6009, Australia. 2BRITElab, Harry Perkins Institute of
Medical Research, QEII Medical Centre, 6 Verdun St, Nedlands, Perth, WA
6009, Australia. 3Australian Research Council Centre of Excellence for
Nanoscale BioPhotonics, School of Medicine, Faculty of Health Sciences,
University of Adelaide, Adelaide, SA 5005, Australia. 4PathWest, Fiona Stanley
Hospital, Robin Warren Drive, Murdoch, WA 6150, Australia. 5Centre for
Microscopy, Characterisation & Analysis, The University of Western Australia,
35 Stirling Highway, Perth, WA 6009, Australia. 6School of Surgery, The
University of Western Australia, 35 Stirling Highway, Perth, WA 6009,
Australia. 7Breast Clinic, Royal Perth Hospital, 197 Wellington Street, Perth,
WA 6000, Australia.
Received: 6 June 2016 Accepted: 27 October 2016
References
1. Overgaard J. Management of the axilla in breast cancer: Implication for
diagnosis, prognosis, treatment, and morbidity. Acta Oncol. 2000;39(3):259–60.
2. Weigelt B, Peterse JL, van’t Veer LJ. Breast cancer metastasis: Markers and
models. Nat Rev Cancer. 2005;5(8):591–602.
3. Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, Benson III
AB, Bosserman LD, Burstein HJ, Cody III H, et al. Sentinel lymph node biopsy
for patients with early-stage breast cancer: American Society of Clinical
Oncology clinical practice guideline update. J Clin Oncol. 2014;32(13):1365–83.
4. Sakorafas GH, Peros G, Cataliotti L. Sequelae following axillary lymph node
dissection for breast cancer. Expert Rev Anticancer Ther. 2006;6(11):1629–38.
5. Valente SA, Levine GM, Silverstein MJ, Rayhanabad JA, Weng-Grumley JG, Ji
L, Holmes DR, Sposto R, Sener SF. Accuracy of predicting axillary lymph
node positivity by physical examination, mammography, ultrasonography,
and magnetic resonance imaging. Ann Surg Oncol. 2012;19(6):1825–30.
6. Fujii T, Yanagita Y, Kinoshita T, Fujisawa T, Hirakata T, Yamaki S, Matsumoto
A, Uchida N, Iijima M, Kuwano H. Accuracy of intraoperative macroscopic
diagnosis of sentinel node metastases in breast cancer: Is accurate
prediction possible? Tumori. 2011;97(1):62–5.
7. Layfield DM, Agrawal A, Roche H, Cutress RI. Intraoperative assessment of
sentinel lymph nodes in breast cancer. Br J Surg. 2011;98(1):4–17.
8. Tanis PJ, Boom RPA, Koops HS, Faneyte IF, Peterse JL, Nieweg OE, Rutgers EJT,
Tiebosch ATMG, Kroon BBR. Frozen section investigation of the sentinel node
in malignant melanoma and breast cancer. Ann Surg Oncol. 2001;8(3):222–6.
9. Creager AJ, Geisinger KR, Shiver SA, Perrier ND, Shen P, Shaw JA, Young PR,
Levine EA. Intraoperative evaluation of sentinel lymph nodes for metastatic
breast carcinoma by imprint cytology. Mod Pathol. 2002;15(11):1140–7.
10. Fischer U, Zachariae O, Baum F, Heyden D, Funke M, Liersch T. The
influence of preoperative MRI of the breasts on recurrence rate in patients
with breast cancer. Eur Radiol. 2004;14(10):1725–31.
11. Diepstraten SCE, Sever AR, Buckens CFM, Veldhuis WB, Dalen T, Bosch
MAAJ, Mali WPTM, Verkooijen HM. Value of preoperative ultrasound-guided
axillary lymph node biopsy for preventing completion axillary lymph node
dissection in breast cancer: A systematic review and meta-analysis. Ann
Surg Oncol. 2014;21(1):51–9.
12. Fuster D, Duch J, Paredes P, Velasco M, Muñoz M, Santamaría G, Fontanillas
M, Pons F. Preoperative staging of large primary breast cancer with
[18F]fluorodeoxyglucose positron emission tomography/computed
tomography compared with conventional imaging procedures. J Clin
Oncol. 2008;26(29):4746–51.
13. Mamou J, Coron A, Oelze ML, Saegusa-Beecroft E, Hata M, Lee P, Machi J,
Yanagihara E, Laugier P, Feleppa EJ. Three-dimensional high-frequency
backscatter and envelope quantification of cancerous human lymph nodes.
Ultrasound Med Biol. 2011;37(3):345–57.
14. Luke GP, Myers JN, Emelianov SY, Sokolov KV. Sentinel lymph node biopsy
revisited: Ultrasound-guided photoacoustic detection of micrometastases
using molecularly targeted plasmonic nanosensors. Cancer Res. 2014;74(19):
5397–408.
15. Luo W, Nguyen FT, Zysk AM, Ralston TS, Brockenbrough J, Marks DL,
Oldenburg AL, Boppart SA. Optical biopsy of lymph node morphology
using optical coherence tomography. Technol Cancer Res Treat.
2005;4(5):539–48.
16. McLaughlin RA, Scolaro L, Robbins P, Hamza S, Saunders C, Sampson DD.
Imaging of human lymph nodes using optical coherence tomography:
Potential for staging cancer. Cancer Res. 2010;70(7):2579–84.
17. Nguyen FT, Zysk AM, Chaney EJ, Adie SG, Kotynek JG, Oliphant UJ, Bellafiore
FJ, Rowland KM, Johnson PA, Boppart SA. Optical coherence tomography:
The intraoperative assessment of lymph nodes in breast cancer. IEEE Eng
Med Biol Mag. 2010;29(2):63–70.
18. Scolaro L, McLaughlin RA, Klyen BR, Wood BA, Robbins PD, Saunders CM,
Jacques SL, Sampson DD. Parametric imaging of the local attenuation
coefficient in human axillary lymph nodes assessed using optical coherence
tomography. Biomed Opt Express. 2012;3(2):366–79.
19. John R, Adie SG, Chaney EJ, Marjanovic M, Tangella KV, Boppart SA.
Three-dimensional optical coherence tomography for optical biopsy
of lymph nodes and assessment of metastatic disease. Ann Surg Oncol.
2013;20(11):3685–93.
20. Scolaro L, McLaughlin RA, Kennedy BF, Saunders CM, Sampson DD. A
review of optical coherence tomography in breast cancer. Photonics Lasers
Med. 2014;3(3):225–40.
21. Grieve K, Mouslim K, Assayag O, Dalimier E, Harms F, Bruhat A, Boccara C,
Antoine M. Assessment of sentinel node biopsies with full-field optical
coherence tomography. Technol Cancer Res Treat. 2015;15(2):266–74.
22. Nolan RM, Adie SG, Marjanovic M, Chaney EJ, South FA, Monroy GL,
Shemonski ND, Erickson-Bhatt SJ, Shelton RL, Bower AJ, et al. Intraoperative
optical coherence tomography for assessing human lymph nodes for
metastatic cancer. BMC Cancer. 2016;16:144.
23. Miyaji K, Furuse A, Nakajima J, Kohno T, Ohtsuka T, Yagyu K, Oka T, Omata S.
The stiffness of lymph nodes containing lung carcinoma metastases.
Cancer. 1997;80(10):1920–5.
24. Swartz MA. The physiology of the lymphatic system. Adv Drug Deliv Rev.
2001;50(1–2):3–20.
25. Doyley MM, Parker KJ. Elastography: General principles and clinical
applications. Ultrasound Clin. 2014;9(1):1–11.
26. Glaser KJ, Manduca A, Ehman RL. Review of MR elastography applications
and recent developments. J Magn Reson Imaging. 2012;36(4):757–74.
27. Choi JJ, Kang BJ, Kim SH, Lee JH, Jeong SH, Yim HW, Song BJ, Jung SS. Role
of sonographic elastography in the differential diagnosis of axillary lymph
nodes in breast cancer. J Ultrasound Med. 2011;30(4):429–36.
28. Evans A, Rauchhaus P, Whelehan P, Thomson K, Purdie CA, Jordan LB,
Michie CO, Thompson A, Vinnicombe S. Does shear wave ultrasound
independently predict axillary lymph node metastasis in women with
invasive breast cancer? Breast Cancer Res Treat. 2014;143(1):153–7.
29. Schmitt JM. OCT elastography: Imaging microscopic deformation and strain
of tissue. Opt Express. 1998;3(6):199–211.
Kennedy et al. BMC Cancer  (2016) 16:874 Page 8 of 9
30. Kennedy BF, Kennedy KM, Sampson DD. A review of optical coherence
elastography: Fundamentals, techniques and prospects. IEEE J Sel Topics
Quantum Electron. 2014;20(2):272–88.
31. Wang S, Larin KV. Optical coherence elastography for tissue characterization:
A review. J Biophotonics. 2015;8(4):279–302.
32. Mulligan JA, Untracht GR, Chandrasekaran SN, Brown CN, Adie SG.
Emerging approaches for high-resolution imaging of tissue biomechanics
with optical coherence elastography. IEEE J Sel Topics Quantum Electron.
2016;22(3):6800520.
33. Kennedy BF, McLaughlin RA, Kennedy KM, Chin L, Curatolo A, Tien A, Latham
B, Saunders CM, Sampson DD. Optical coherence micro-elastography:
Mechanical-contrast imaging of tissue microstructure. Biomed Opt Express.
2014;5(7):2113–24.
34. Kennedy BF, McLaughlin RA, Kennedy KM, Chin L, Wijesinghe P, Curatolo A,
Tien A, Ronald M, Latham B, Saunders CM, et al. Investigation of optical
coherence micro-elastography as a method to visualize cancers in human
breast tissue. Cancer Res. 2015;75(16):3236–45.
35. Wang RK, Kirkpatrick S, Hinds M. Phase-sensitive optical coherence
elastography for mapping tissue microstrains in real time. Appl Phys Lett.
2007;90(16):164105.
36. Deserno TM, editor. Biomedical image processing. Berlin Heidelberg:
Springer; 2011.
37. Lopez JI, Kang I, You W-K, McDonald DM, Weaver VM. In situ force mapping
of mammary gland transformation. Integr Biol. 2011;3(9):910–21.
38. Plodinec M, Loparic M, Monnier CA, Obermann EC, Zanetti-Dallenbach R,
Oertle P, Hyotyla JT, Aebi U, Bentires-Alj M, Lim RYH, et al. The nanomechanical
signature of breast cancer. Nat Nanotechnol. 2012;7(11):757–65.
39. Weaver DL. Pathology evaluation of sentinel lymph nodes in breast cancer:
Protocol recommendations and rationale. Mod Pathol. 2010;23:S26–32.
40. Li C, Guan G, Huang Z, Johnstone M, Wang RK. Noncontact all-optical
measurement of corneal elasticity. Opt Lett. 2012;37(10):1625–7.
41. Wang S, Lopez III AL, Morikawa Y, Tao G, Li J, Larina IV, Martin JF, Larin KV.
Noncontact quantitative biomechanical characterization of cardiac muscle
using shear wave imaging optical coherence tomography. Biomed Opt
Express. 2014;5(7):1980–92.
42. Nguyen T-M, Song S, Arnal B, Huang Z, O’Donnell M, Wang RK. Visualizing
ultrasonically induced shear wave propagation using phase-sensitive
optical coherence tomography for dynamic elastography. Opt Lett.
2014;39(4):838–41.
43. Kennedy KM, Chin L, McLaughlin RA, Latham B, Saunders CM, Sampson DD,
Kennedy BF. Quantitative micro-elastography: Imaging of tissue elasticity
using compression optical coherence elastography. Sci Rep. 2015;5:15538.
44. Dong L, Wijesinghe P, Dantuono JT, Sampson DD, Munro PRT, Kennedy
BF, Oberai AA. Quantitative compression optical coherence elastography
as an inverse elasticity problem. IEEE J Sel Topics Quantum Electron.
2016;22(3):6802211.
45. Curatolo A, Villiger M, Lorenser D, Wijesinghe P, Fritz A, Kennedy BF,
Sampson DD. Ultrahigh-resolution optical coherence elastography. Opt Lett.
2016;41(1):21–4.
46. Kennedy BF, Malheiro FG, Chin L, Sampson DD. Three-dimensional optical
coherence elastography by phase-sensitive comparison of C-scans.
J Biomed Opt. 2014;19(7):076006.
47. Kirk RW, Kennedy BF, Sampson DD, McLaughlin RA. Near video-rate optical
coherence elastography by acceleration with a graphics processing unit.
J Lightw Technol. 2015;33(16):3481–5.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Kennedy et al. BMC Cancer  (2016) 16:874 Page 9 of 9
